Authors:
Engelborghs, S
De Brabander, M
De Cree, J
D'Hooge, R
Geerts, H
Verhaegen, H
De Deyn, PP
Citation: S. Engelborghs et al., Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of theAlzheimer type, NEUROCHEM I, 34(6), 1999, pp. 523-530
Authors:
De Deyn, PP
Rabheru, K
Rasmussen, A
Bocksberger, JP
Dautzenberg, PLJ
Eriksson, S
Lawlor, BA
Citation: Pp. De Deyn et al., A randomized trial of risperidone, placebo, and haloperidol for behavioralsymptoms of dementia, NEUROLOGY, 53(5), 1999, pp. 946-955
Authors:
Hulstaert, F
Blennow, K
Ivanoiu, A
Schoonderwaldt, HC
Riemenschneider, M
De Deyn, PP
Bancher, C
Cras, P
Wiltfang, J
Mehta, PD
Iqbal, K
Pottel, H
Vanmechelen, E
Vanderstichele, H
Citation: F. Hulstaert et al., Improved discrimination of AD patients using beta-amyloid((1-42)) and tau levels in CSF, NEUROLOGY, 52(8), 1999, pp. 1555-1562
Authors:
D'Hooge, R
Coenen, R
Gieselmann, V
Lullmann-Rauch, R
De Deyn, PP
Citation: R. D'Hooge et al., Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice, BRAIN RES, 847(2), 1999, pp. 352-356
Authors:
Stevens, I
Van Osta, P
Geerts, H
Verheyen, G
Van Hauwaert, ML
Cras, P
Engelborghs, S
De Deyn, PP
Martin, JJ
Van Broeckhoven, C
Moens, L
Citation: I. Stevens et al., Processing of apolipoprotein E in cerebrospinal fluid of patients with Alzheimer's disease, ALZHEIM REP, 1(4), 1998, pp. 257-265
Authors:
D'Hooge, R
Raes, A
Hiramatsu, M
Mori, A
Van Bogaert, PP
De Deyn, PP
Citation: R. D'Hooge et al., Effects of the competitive N-methyl-D-aspartate antagonist CGP37849 and its ethylester CGP39551 on N-methyl-D-aspartate-evoked whole-cell currents incultured spinal neurones and on vestibular stimulation-induced seizures inEL mice, ARZNEI-FOR, 48(12), 1998, pp. 1121-1125